Events

Recall of COBAS LIAT ANALYZER

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ROCHE DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    47918
  • Event Risk Class
    III
  • Event Initiated Date
    2017-11-10
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    A situation was identified where the cobas liat analyzer was manufactured and distributed with 3 assay scripts pre-loaded on the instrument. one of the assay script (cobas liat strep a) is not yet licenced in canada. however there is no user-impact since the assay is not available in canada and is not functional on the analyzer leading to no consequence on result reliability.

Device

COBAS LIAT ANALYZER
  • Model / Serial
    Model Catalog: 07341920190 (Lot serial: all)
  • Product Description
    COBAS LIAT ANALYZER
  • Manufacturer
    ROCHE DIAGNOSTICS

Manufacturer

ROCHE DIAGNOSTICS
  • Manufacturer Address
    LAVAL
  • Manufacturer Parent Company (2017)
    Roche Holding AG
  • Source
    HC